US Patent 10072094 Compositions and methods for tumor transduction
Patent 10072094 was granted and assigned to Aleta Biotherapeutics on September, 2018 by the United States Patent and Trademark Office.
All edits
Edits on 8 Dec, 2023
Golden AI
Edits made to:
Article (+211 characters)
Article
Patent abstract
The invention relates to cancer therapeutics, in particular, the system of making cancer cells more susceptible to effector cells by introduction of cellular therapy targets into the cancer cells.
Edits on 23 Apr, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
100720940
Date of Patent
September 11, 2018
0Patent Application Number
156705350
Date Filed
August 7, 2017
0Patent Citations Received
Patent Primary Examiner
Edits on 27 Mar, 2023
Golden AI
Infobox
Patent Citations Received
Edits on 25 Sep, 2022
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
100720940
Date of Patent
September 11, 2018
0Patent Application Number
156705350
Date Filed
August 7, 2017
0Patent Citations Received
Patent Primary Examiner
Edits on 4 Feb, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent citations received
Edits on 22 Jan, 2022
Golden AI
Edits made to:
Infobox (+9 properties)
US Patent 10072094 Compositions and methods for tumor transduction
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
10072094
Date of patent
September 11, 2018
Patent application number
15670535
Date Filed
August 7, 2017
Patent primary examiner
Find more entities like US Patent 10072094 Compositions and methods for tumor transduction
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
